Choose Bio-Rad as your partner in the fight against COVID-19.
Contact a Bio-Rad sales representative today.
Thank you for your submission,
Antibody testing is a critical component in overcoming the challenges posed by the SARS-CoV-2 virus.
Reliable antibody detection and differentiation play an important role in the management of COVID-19 patients, as well as in improving our immunological understanding of this complex disease. Blood-based immunoassays designed to detect antibodies to SARS-CoV-2 are critical in determining the full scope of COVID-19 in our population and combating the pandemic.
BioPlex 2200 SARS-CoV-2 IgG Panel
Each COVID-19 patient develops a unique antibody response to the SARS-CoV-2 virus. As a semi-quantitative multiplex assay, the BioPlex 2200 SARS-CoV-2 IgG Panel provides the highest definition picture of a patient's IgG antibody response on a fully-automated random access platform.
Learn more ▸
Thank you for your submission, test. A specialist will contact you shortly.
This test has met requirements for applying the CE-mark in Europe. Please contact your Bio-Rad local representative to check the availability in your country.